Cumulus Neuroscience
United Kingdom
activeseries-a
series-a
Stage
About
Cumulus Neuroscience develops the NeuLogiq Platform, which uses a dry-sensor EEG headset and AI-powered tablet assessments to measure brain function across multiple domains, including cognition, mood, and language, enabling more efficient and objective data collection in neuroscience clinical trials and patient care.
Explore Cumulus Neuroscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.